Following incubation with the LN229-derived sEVs, recipient GBM cells exhibited an increase in MMP-2 secretion and activity (Fig. 4B), FITC-gelatin degradation (Fig. 4C), and invadopodia formation and activity (Fig. 4D, E). Here, MMP2 is linked to glioblastoma.